<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03498820</url>
  </required_header>
  <id_info>
    <org_study_id>P171003J</org_study_id>
    <nct_id>NCT03498820</nct_id>
  </id_info>
  <brief_title>Analgesia-Nociception Index Guided Intraoperative Remifentanil Administration Versus Standard Practice:Evaluation of Perioperative Opioid Use</brief_title>
  <acronym>MONIDOL-ANI</acronym>
  <official_title>Analgesia-Nociception Index Guided Intraoperative Remifentanil Administration Versus Standard Practice : Evaluation of Perioperative Opioid Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares two groups of patients undergoing a gynecological surgey under general&#xD;
      anesthesia: one group in which intraoperative analgesia is guided by the&#xD;
      Analgesia-nociception index, and another group in which intraoperative analgesia is managed&#xD;
      as in standard practice. The objective is to assess if the Analgesia Nociception Index may&#xD;
      result in a decrease in total analgesic drugs consumption, a decrease in post-operative pain&#xD;
      and in chronic pain development.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 19, 2018</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">December 19, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative remifentanil consumption</measure>
    <time_frame>up to 7 hours after the beginning of general anesthesia</time_frame>
    <description>total dose of remifentanil administered to the patient during general anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative morphine consumption</measure>
    <time_frame>obtained 24 hours after the end of general anesthesia</time_frame>
    <description>total dose of morphine administered to the patient to manage postoperative pain during the first 24 hours following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent pain</measure>
    <time_frame>: obtained one month after surgery</time_frame>
    <description>phone interview asking the patient if she still feels pain related to the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent pain</measure>
    <time_frame>Obtained three months after surgery</time_frame>
    <description>phone interview asking the patient if she still feels pain related to the surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Pain</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Analgesia Nociception Index</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative remifentanil administration guided by the Analgesia Nociception Index</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual practice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative remifentanil administration managed in standard practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Analgesia Nociception Index</intervention_name>
    <description>: Non invasive monitor based on heart rate variability analysis, assessing the parasympathetic nervous activity</description>
    <arm_group_label>Analgesia Nociception Index</arm_group_label>
    <other_name>ANI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>intravenous short-acting opioid routinely administered during general anesthesia</description>
    <arm_group_label>Usual practice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective gynecological surgery under general anesthesia&#xD;
&#xD;
          -  Duration of surgery 1-7 hours&#xD;
&#xD;
          -  Duration of hospital stay &gt; 24 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic pain&#xD;
&#xD;
          -  chronic analgesic medication&#xD;
&#xD;
          -  neurologic disease&#xD;
&#xD;
          -  psychiatric disease&#xD;
&#xD;
          -  history of addiction&#xD;
&#xD;
          -  kidney or liver failure&#xD;
&#xD;
          -  allergy to any anesthetic or analgesic drug&#xD;
&#xD;
          -  BMI &gt; 35&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nada SABOURDIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'Anesthésie-réanimation chirurgicale - Hôpital Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 26, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Analgesia-Nociception Index (ANI)</keyword>
  <keyword>General anesthesia</keyword>
  <keyword>Opioids</keyword>
  <keyword>Remifentanil</keyword>
  <keyword>Pain</keyword>
  <keyword>Monitoring</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

